midazolam and panobinostat

midazolam has been researched along with panobinostat in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, D; Goh, WH; Soh, CK; Wang, H	1
Chun, DY; Einolf, HJ; Gu, H; He, H; Lin, W; Mangold, JB; Wang, L; Won, CS	1

Other Studies

2 other study(ies) available for midazolam and panobinostat

Article	Year
Design, Synthesis, and Preclinical Evaluation of Fused Pyrimidine-Based Hydroxamates for the Treatment of Hepatocellular Carcinoma. Journal of medicinal chemistry, 2018, 02-22, Volume: 61, Issue:4 Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Screening Assays, Antitumor; Heterografts; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyrimidines; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2018
Physiologically Based Pharmacokinetic Model Predictions of Panobinostat (LBH589) as a Victim and Perpetrator of Drug-Drug Interactions. Drug metabolism and disposition: the biological fate of chemicals, 2017, Volume: 45, Issue:12 Topics: Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Enzyme Induction; Gastric Acidity Determination; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Microsomes, Liver; Midazolam; Models, Biological; Oxidation-Reduction; Panobinostat; Rifampin	2017

Article

Year

Design, Synthesis, and Preclinical Evaluation of Fused Pyrimidine-Based Hydroxamates for the Treatment of Hepatocellular Carcinoma.

Journal of medicinal chemistry, 2018, 02-22, Volume: 61, Issue:4

Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Screening Assays, Antitumor; Heterografts; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyrimidines; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2018

Physiologically Based Pharmacokinetic Model Predictions of Panobinostat (LBH589) as a Victim and Perpetrator of Drug-Drug Interactions.

Drug metabolism and disposition: the biological fate of chemicals, 2017, Volume: 45, Issue:12

Topics: Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Enzyme Induction; Gastric Acidity Determination; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Microsomes, Liver; Midazolam; Models, Biological; Oxidation-Reduction; Panobinostat; Rifampin

2017